IL71953A - Malaria associated antigen,process for preparation thereof and vaccine comprising it - Google Patents

Malaria associated antigen,process for preparation thereof and vaccine comprising it

Info

Publication number
IL71953A
IL71953A IL71953A IL7195384A IL71953A IL 71953 A IL71953 A IL 71953A IL 71953 A IL71953 A IL 71953A IL 7195384 A IL7195384 A IL 7195384A IL 71953 A IL71953 A IL 71953A
Authority
IL
Israel
Prior art keywords
vaccine
preparation
associated antigen
malaria associated
malaria
Prior art date
Application number
IL71953A
Other languages
English (en)
Other versions
IL71953A0 (en
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of IL71953A0 publication Critical patent/IL71953A0/xx
Publication of IL71953A publication Critical patent/IL71953A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/43Protozoan antigens
    • A61K40/438Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL71953A 1983-06-10 1984-05-29 Malaria associated antigen,process for preparation thereof and vaccine comprising it IL71953A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58103901A JPS59227827A (ja) 1983-06-10 1983-06-10 マラリア原虫由来糖鎖関連抗原及びその製造法

Publications (2)

Publication Number Publication Date
IL71953A0 IL71953A0 (en) 1984-09-30
IL71953A true IL71953A (en) 1987-10-30

Family

ID=14366322

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71953A IL71953A (en) 1983-06-10 1984-05-29 Malaria associated antigen,process for preparation thereof and vaccine comprising it

Country Status (13)

Country Link
US (1) US4643896A (da)
EP (1) EP0129173A3 (da)
JP (1) JPS59227827A (da)
KR (1) KR910002521B1 (da)
AU (1) AU565489B2 (da)
CA (1) CA1231051A (da)
DK (1) DK282384A (da)
ES (1) ES8600937A1 (da)
IL (1) IL71953A (da)
IN (1) IN160524B (da)
OA (1) OA07721A (da)
PH (1) PH21427A (da)
ZA (1) ZA844263B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
WO1989001785A1 (en) * 1987-09-04 1989-03-09 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
US5264342A (en) * 1988-05-10 1993-11-23 Verigen, Inc. Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
FR2665909B1 (fr) * 1990-08-14 1992-11-13 Pasteur Institut Polypeptides de surface de globules rouges infectes par p. falciparum et compositions immunogenes les contenant.
JPH06502723A (ja) * 1990-11-09 1994-03-24 ヴェリジェン,インコーポレーテッド 抗体を検出する分析系の感度及び/又は特異性の決定方法
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
ES2861359T3 (es) * 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
EP3134146B1 (en) 2014-04-24 2024-12-25 ExThera Medical Corporation Method for removing bacteria from blood using high flow rate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469457A (en) * 1945-09-17 1949-05-10 Univ Tennessee Res Corp Process for producing an antigen for use in the diagnosis of malaria and product thereof
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
DE3280028D1 (en) * 1981-05-21 1989-12-28 Wellcome Found Protozoal antigen
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates

Also Published As

Publication number Publication date
IL71953A0 (en) 1984-09-30
PH21427A (en) 1987-10-15
DK282384A (da) 1984-12-11
EP0129173A2 (en) 1984-12-27
CA1231051A (en) 1988-01-05
US4643896A (en) 1987-02-17
OA07721A (en) 1985-08-30
EP0129173A3 (en) 1985-07-24
AU2894884A (en) 1984-12-13
DK282384D0 (da) 1984-06-08
ES533250A0 (es) 1985-10-16
KR910002521B1 (ko) 1991-04-23
IN160524B (da) 1987-07-18
KR850000247A (ko) 1985-02-26
JPS59227827A (ja) 1984-12-21
AU565489B2 (en) 1987-09-17
ES8600937A1 (es) 1985-10-16
ZA844263B (en) 1985-01-30

Similar Documents

Publication Publication Date Title
IL68749A (en) Modified antigens,their preparation and vaccines containing them
OA09200A (en) Vaccines for malaria.
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
EP0143848A4 (en) SILICON BASE FOR TOOTHPASTE AND THEIR PRODUCTION PROCESS.
GB9209718D0 (en) Hcg-hlh receptor and hcg-hlh receptor-hch complex as antigens,antibodies thereto and contraceptive vaccine
IL65835A0 (en) Protozoal antigen,its preparation and vaccine containing it
IL82235A (en) Immunogen complexes, their preparation and vaccines comprising them
EP0285391A3 (en) Organopolysiloxane emulsion and method for the preparation thereof
IL65496A0 (en) Protozoal antigen,its preparation and vaccine containing it
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
YU18286A (en) Process for obtaining vaccine against malaria
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
EP0275196A3 (en) Protein copolymer malaria vaccine
EP0290565A4 (en) VACCINE CONTAINING TICK ANTIGENS.
ZA88197B (en) Protein copolymer malaria vaccine
IL96579A0 (en) Malaria vaccine
EP0124548A4 (en) BABESIOSIS ANTIGEN AND PREPARATION METHOD.
ZA846580B (en) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
HU902652D0 (en) Process for the preparation of malaria vaccine
HUT43107A (en) Process for producing vaccine against melanome
EG16749A (en) Malaria associated antigen and preparing process thereof
FR2550942B1 (fr) Vaccin contre le paludisme et procede de preparation de ce vaccin
GB8630851D0 (en) Babesia divergens antigen & vaccine